The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
AACR designates this educational activity for a maximum of 24.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
Cancer metastasis is the most lethal attribute of cancer. More than 90% of the morbidity and mortality due to cancer relates to the development of secondary tumors. Improvement of cure rates and quality of life are dependent primarily upon control and/or prevention of cancer metastasis.
The American Association for Cancer Research and the International Metastasis Research Society have joined to present a special conference on the biology of cancer metastasis. This conference will bring together investigators from around the world who will contribute expertise on the basic science and clinical translation of basic science findings to practice. Oncologists, internists, and oncology nurses will also benefit from the information shared. This conference will incorporate traditional areas of metastasis research (e.g., invasion, adhesion, motility) as well as new concepts related to metastasis control (e.g., dormancy, quorum sensing, clinical trials designed for anti-metastatic agents, and systems biology approaches).
The process of metastasis, while clinically important, is understudied relative to the budget of the National Cancer Institute (0.5% of NCI-funded grants focus on the problem of metastasis). Therefore, it is essential to recruit new investigators to tackle this most important of clinical problems. In addition to recruiting new researchers, dissemination and exchange of information is essential for a concerted improvement in our knowledge base as well as translational potential.
After participating in this CME activity, physicians should be able to:
- Explain how tumor cell-host cell interactions impact the development of cancer metastases.
- Describe developmental processes (EMT and stem cell niches) that are involved in metastasis.
- Identify new genetic and biochemical markers that determine metastatic potential and articulate how those might be used to differentiate patients’ likelihood of developing overt metastases.
Information presented at AACR-sponsored CME activities will be unbiased and based on scientific evidence. AACR will provide information that Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information is available in the Program and Proceedings of this conference.
CLAIMING CME CREDIT
The deadline for the submission of requests for credit for CME has elapsed. Please contact the AACR Office of CME at firstname.lastname@example.org or (215) 440-9300 with further inquiries.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
Supporters of this activity are listed in the Final Program.